GCP
AGTC

GSA Capital Partners’s Applied Genetic Technologies Corporation AGTC Stock Holding History

GSA Capital Partners’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-583,510
Closed -$1.76M – 1939
2021
Q3 		$1.76M Buy
583,510
+458,420
+366% +$1.63M 0.18% 90
2021
Q2 		$489K Buy
+125,090
New +$519K 0.06% 642
2021
Q1 		– Sell
-15,113
Closed -$62K – 1617
2020
Q4 		$62K Buy
+15,113
New +$74.2K 0.01% 1130
2018
Q1 		– Sell
-66,900
Closed -$241K – 1891
2017
Q4 		$241K Sell
66,900
-87,800
-57% -$332K 0.01% 1328
2017
Q3 		$611K Buy
154,700
+4,500
+3% +$20.7K 0.04% 843
2017
Q2 		$766K Sell
150,200
-5,000
-3% -$28.1K 0.05% 741
2017
Q1 		$1.07M Buy
155,200
+41,900
+37% +$327K 0.06% 594
2016
Q4 		$1.06M Buy
113,300
+67,100
+145% +$604K 0.06% 528
2016
Q3 		$452K Buy
46,200
+21,000
+83% +$283K 0.02% 1115
2016
Q2 		$356K Buy
25,200
+4,000
+19% +$62.4K 0.02% 1293
2016
Q1 		$296K Buy
+21,200
New +$311K 0.02% 1307

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GSA Capital Partners's AGTC Position: Q4 2021 in Review

GSA Capital Partners sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2021, closing a stake of 583,510 shares — an estimated $1.76M sold.

GSA Capital Partners first reported a position in AGTC in Q1 2016 and held it in 11 quarters. The position peaked at $1.76M in Q3 2021. 55 funds tracked by Wall St. Rank hold AGTC as of Q4 2021.

  • GSA Capital Partners reported no remaining Applied Genetic Technologies Corporation position as of Q4 2021 after selling out during the quarter.
  • GSA Capital Partners sold 583,510 Applied Genetic Technologies Corporation shares in Q4 2021, an estimated $1.76M.
  • GSA Capital Partners first reported a position in Applied Genetic Technologies Corporation in Q1 2016 and held it in 11 quarters.
  • GSA Capital Partners's Applied Genetic Technologies Corporation position peaked at $1.76M in Q3 2021.
  • 55 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2021.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.